BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36993762)

  • 1. Role of Lactate in the Regulation of Transcriptional Activity of Breast Cancer-Related Genes and Epithelial-to-Mesenchymal Transition Proteins: A Compassion of MCF7 and MDA-MB-231 Cancer Cell Lines.
    San-Millan I; Martinez JL; Pickard SL; Yu H; Hirsch FR; Rivard CJ; Brooks GA
    bioRxiv; 2023 Sep; ():. PubMed ID: 36993762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q
    Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC
    Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells.
    San-Millán I; Julian CG; Matarazzo C; Martinez J; Brooks GA
    Front Oncol; 2019; 9():1536. PubMed ID: 32010625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
    Do HTT; Cho J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
    Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
    Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3.
    Liu S; Dong Y; Wang Y; Hu P; Wang J; Wang RY
    Biomed J; 2021 Dec; 44(6 Suppl 1):S84-S92. PubMed ID: 35652598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of aerobic glycolysis is a pivotal regulator of tumor progression.
    Zare ME; Kansestani AN; Hemmati S; Mansouri K; Vaisi-Raygani A
    J Diabetes Metab Disord; 2021 Jun; 20(1):523-531. PubMed ID: 34178852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
    Shetti D; Zhang B; Fan C; Mo C; Lee BH; Wei K
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
    Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
    Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucoidan inhibits epithelial-to-mesenchymal transition via regulation of the HIF-1α pathway in mammary cancer cells under hypoxia.
    Li W; Xue D; Xue M; Zhao J; Liang H; Liu Y; Sun T
    Oncol Lett; 2019 Jul; 18(1):330-338. PubMed ID: 31289504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells.
    Kashyap A; Umar SM; Dev J R A; Prasad CP
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2177-2184. PubMed ID: 34319041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
    Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
    Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.